new computational Modeling Framework Revolutionizes Cancer Research, Enabling “Virtual Clinical Trials”
Baltimore, MD – A groundbreaking new computational modeling framework developed by researchers at the University of Maryland School of Medicine’s Institute for Genomic Sciences (IGS) is poised to transform cancer research, offering a powerful new approach to understanding tumor behavior, predicting treatment responses, and ultimately, improving patient outcomes. This innovative tool, leveraging cutting-edge technologies like spatial transcriptomics, allows scientists to create detailed, computerized simulations of biological processes – effectively building a “virtual cell laboratory” for experimentation.
The Challenge of Complex Biological Systems
For decades, cancer research has been hampered by the sheer complexity of the disease. Tumors aren’t simply collections of cancerous cells; they exist within intricate ecosystems of immune cells, fibroblasts, and othre non-cancerous components. Understanding how these components interact is crucial for developing effective therapies. Customary research methods, while valuable, are frequently enough limited by cost, time, and the inherent risks associated with in vivo experimentation.
“I am struck by how many rules of biology we don’t yet know,” explains Elana J. Fertig,PhD,Director of IGS,Associate Director of Quantitative Sciences,and Professor of Medicine and Epidemiology at UMSOM,and a lead author on the study. “Adapting this approach to genomics technologies gives us a virtual cell laboratory in which we can conduct experiments to test the implications of cellular rules entirely in silico.”
From Weather Prediction to Predictive Oncology
The foundation of this new framework draws an unexpected parallel: weather prediction. Dr. Fertig, whose background is in atmospheric science, recognized the potential to apply the principles of modeling complex systems to the biological realm. Just as meteorologists use data and algorithms to forecast weather patterns, this new tool uses genomic data to predict how tumors will respond to treatment.
Modeling the Immune System’s Role in Cancer Progression
the IGS team initially focused on breast cancer, successfully modeling a scenario where the immune system, rather than suppressing tumor growth, inadvertently promotes invasion and spread. This model was then adapted to simulate a real-world immunotherapy clinical trial for pancreatic cancer – a notoriously difficult cancer to treat.
Using genomic data from untreated pancreatic cancer tissue, the model accurately predicted varying responses to immunotherapy among virtual “patients.” This highlights the critical importance of considering the cellular ecosystem when designing precision oncology strategies. The team further utilized spatial genomics technology to map the complex communication between tumor cells and fibroblasts, a dense structural component often surrounding pancreatic tumors.This allowed them to track tumor growth and progression directly from real patient tissue within the simulated surroundings.
A “Sandbox” for Immunological Investigation
The benefits of this approach are important. As Dr. johnson explains, “What makes these models so exciting…is that they can be informed, initialized, and built upon using both laboratory and human genomics data. Immune cells are amazing and follow rules of behavior that can be programmed into one of these models. So, as a notable example, we can take data and treat it as a snapshot of what the human immune system is doing, and this framework gives us a sandbox to freely investigate our hypotheses of what’s happening there over time without extra costs or risk to patients.”
Open Source and Broadly Applicable
Recognizing the potential impact of this technology, the research team has made the underlying grammar of the model open source, ensuring accessibility for the wider scientific community. “By making this tool accessible to the scientific community, we are providing a path forward to standardize such models and make them generally accepted,” says Dr. Bergman.
To demonstrate its versatility,researchers at Johns hopkins School of medicine successfully applied the framework to simulate brain development,showcasing its potential beyond cancer research.
The Future of Cancer Research: Digital Twins and Virtual Clinical Trials
The implications of this work are far-reaching. Mark T. Gladwin, MD, vice President for Medical Affairs at the University of Maryland, Baltimore, envisions a future where this technology enables “digital twins” – personalized, computerized representations of patients – and “virtual clinical trials,” significantly accelerating the drug development process and tailoring treatments to individual needs.
This research, funded by the National Foundation for Cancer Research, the National Cancer Institute (NCI), and other organizations, represents a significant leap forward in our ability to understand and combat cancer. the IGS team, in collaboration with researchers at Johns Hopkins University and Oregon Health sciences University, is continuing to refine and expand the software, paving the way for a new era of data-driven, predictive oncology.
Key Takeaways:
Novel Framework: A new computational modeling framework allows for detailed simulations of biological processes in cancer.
Spatial Genomics Integration: Leverages cutting-edge technologies like spatial transcriptomics for a more comprehensive understanding of tumor ecosystems.
Predictive Power: Accurately predicts treatment responses and tumor behavior based on genomic data. Open Source Accessibility: The tool is freely available to the scientific community, fostering collaboration and standardization.